Lobo D, Tuñón M, Villarreal I, Brea B, García-Berrocal J R
Department of Otolaryngology,Hospital Universitario El Escorial,Universidad Francisco de Vitoria,Madrid,Spain.
Department of Radiology,Hospital Universitario Puerta de Hierro,Universidad Autónoma de Madrid,Spain.
J Laryngol Otol. 2018 Jun;132(6):554-559. doi: 10.1017/S0022215118000749. Epub 2018 Jun 11.
To evaluate the presence of endolymphatic hydrops in patients with immune-mediated inner-ear disease.
The presence of endolymphatic hydrops was prospectively evaluated in 17 patients clinically diagnosed with secondary (n = 5) or primary (n = 12) immune-mediated inner-ear disease, who attended the ENT department of a tertiary care centre for evaluation or treatment over the previous year. All patients underwent magnetic resonance imaging of the temporal bone.
Intratympanic gadolinium three-dimensional magnetic resonance imaging diagnosed hydrops in 11 of 12 patients with primary immune-mediated inner-ear disease (92 per cent). Of these, seven patients (64 per cent) presented only cochlear (n = 5) or predominantly cochlear (n = 2) hydrops. A positive magnetic resonance imaging result was observed in only one of five patients with secondary immune-mediated inner-ear disease (20 per cent).
This study confirms the presence of endolymphatic hydrops in immune-mediated inner-ear disease patients. The virtual absence of hydrops in patients with secondary immune-mediated inner-ear disease is remarkable, although firm conclusions cannot be drawn; this should be explored in a multicentre study with a larger sample of patients. A different immune reaction without development of endolymphatic hydrops should not be ruled out in secondary immune-mediated inner-ear disease patients.
评估免疫介导性内耳疾病患者内淋巴积水的情况。
对17例临床诊断为继发性(n = 5)或原发性(n = 12)免疫介导性内耳疾病的患者进行前瞻性评估,这些患者在前一年到三级医疗中心的耳鼻喉科接受评估或治疗。所有患者均接受了颞骨磁共振成像检查。
鼓室内注射钆剂三维磁共振成像诊断出12例原发性免疫介导性内耳疾病患者中有11例存在积水(92%)。其中,7例患者(64%)仅表现为耳蜗积水(n = 5)或主要为耳蜗积水(n = 2)。5例继发性免疫介导性内耳疾病患者中只有1例磁共振成像结果呈阳性(20%)。
本研究证实了免疫介导性内耳疾病患者存在内淋巴积水。继发性免疫介导性内耳疾病患者几乎不存在积水,这一点值得关注,尽管无法得出确切结论;这应在一项纳入更多患者样本的多中心研究中进行探索。在继发性免疫介导性内耳疾病患者中,不应排除存在未发展为内淋巴积水的不同免疫反应。